ZymoGenetics - 2/17

Entry	Author	Date	Location
Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive	Carl Weissman	09/14/10	Seattle
What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots?	Luke Timmerman	09/13/10	Seattle
ZymoGenetics Reaches the End, Stratos Genomics Nabs $4M, Children’s New Ventilator, & More Seattle-Area Life Sciences News	Luke Timmerman	09/09/10	Seattle
ZymoGenetics Reaches End of Road in Seattle, Faces Uncertain Future, Potential Job Cuts	Luke Timmerman	09/07/10	Seattle
ZymoGenetics, Seattle Biotech Pioneer, Acquired by Bristol-Myers for $885M	Luke Timmerman	09/07/10	Seattle
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas	Luke Timmerman	08/05/10	Seattle
Xconomy Seattle’s Top 20 Stories of the Quarter: The Quest for the Land Speed Record, Dendreon Makes History, & Geoff Entress Up Close	Luke Timmerman & Gregory T. Huang	07/02/10	Seattle
Biotech Drug Discovery in Seattle: A Look Back	Stewart Lyman	06/11/10	Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/10	Seattle
Wings Replaces Kraemer With Cramer, Adding Elder Statesman of Northwest Life Sciences	Luke Timmerman	06/10/10	Seattle
ZymoGenetics Melanoma Drug Passes Small Study, Gets Overshadowed by Bristol-Myers	Luke Timmerman	06/05/10	Seattle
Generating a Human Return on Investment: Three Young Scientists Pursue Dreams	Luke Timmerman	05/25/10	Seattle
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs	Luke Timmerman	03/19/10	Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	03/18/10	Seattle
Bruce Montgomery Joins Zymo Board	Luke Timmerman	03/11/10	Seattle
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It	Stewart Lyman	03/05/10	Seattle
Inside the McKinstry Innovation Center: A First Look at Seattle’s Big Cleantech Hope	Gregory T. Huang	02/12/10	Seattle
Biotech Bigwig, Steve Burrill, Brings National Profile to Local Conference	Luke Timmerman	01/29/10	Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News	Luke Timmerman	01/14/10	Seattle
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News	Gregory T. Huang	01/12/10	Seattle
ZymoGenetics Closes $90M Deal	Luke Timmerman	01/11/10	Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News	Luke Timmerman	01/07/10	Seattle
ZymoGenetics Gets $79M in Stock Sale	Luke Timmerman	01/07/10	Seattle
ZymoGenetics On the Prowl to Raise $85M in Stock Deal	Luke Timmerman	01/06/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News	Luke Timmerman	12/24/09	Seattle
Oncothyreon CEO on Next-Generation Cancer Vaccines, Two Key Zymonites, and Serious Luck	Luke Timmerman	12/23/09	Seattle
Zulily Gets Funded, Ontela Merges with Photobucket, OncoGenex Secures $60M from Teva, & More Seattle-Area Deals News	Gregory T. Huang	12/22/09	Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away	Luke Timmerman	12/21/09	Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News	Luke Timmerman	12/17/09	Seattle
Page 2 of 6	« previous page · next page »

Entry

Author

Date

Location

Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive

Carl Weissman

09/14/10

Seattle

What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots?

Luke Timmerman

09/13/10

Seattle